Amneal Pharmaceuticals Inc (AMRX)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Amneal Pharmaceuticals Inc

Healthcare (1114)

908-947-3120

400 Crossing Boulevard, 3rd Floor, Bridgewater

@amnealpharma

Nächster Verdiensttermin

Neueste SEC-Einreichungen

AMRX's Discussions on Twitter

Compare AMRX vs TAK, ZTS, HLN, TEVA, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AMRX Amneal Pharmaceuticals Inc	12.43	3.81B	3.02B	127.93M	225.64M	0.2213
TAK Takeda Pharmaceutical Co Adr	18.52	57.72B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	118.21	49.11B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.01	44.59B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.12	33.02B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	592.98	25.79B	3.18B	1.33B	1.04B	27.90

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Overweight
2025-06-06	Eingeleitet	Goldman	Buy
2025-02-24	Hochstufung	JP Morgan	Neutral → Overweight
2024-09-06	Hochstufung	JP Morgan	Underweight → Neutral
2021-04-07	Fortgesetzt	RBC Capital Mkts	Sector Perform
2021-03-08	Hochstufung	Goldman	Sell → Buy
2020-12-14	Hochstufung	Barclays	Equal Weight → Overweight
2020-12-14	Hochstufung	Guggenheim	Neutral → Buy
2020-07-27	Eingeleitet	Goldman	Sell
2020-05-12	Hochstufung	Guggenheim	Sell → Neutral
2019-12-12	Herabstufung	Raymond James	Outperform → Mkt Perform
2019-11-12	Herabstufung	JP Morgan	Neutral → Underweight
2019-11-07	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2019-07-22	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2019-07-11	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2019-07-08	Hochstufung	Piper Jaffray	Neutral → Overweight
2019-06-11	Eingeleitet	Barclays	Equal Weight
2019-05-21	Hochstufung	Raymond James	Mkt Perform → Strong Buy
2019-03-20	Eingeleitet	SunTrust	Buy
2019-03-08	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2018-12-14	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2018-10-16	Herabstufung	SunTrust	Buy → Hold
2018-08-13	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2018-07-23	Eingeleitet	Morgan Stanley	Overweight
2018-06-22	Eingeleitet	B. Riley FBR, Inc.	Buy

Alle ansehen

Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten

Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Compare AMRX vs TAK, ZTS, HLN, TEVA, UTHR

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten

Tudor Investment Corp ET AL Takes Position in Amneal Pharmaceuticals, Inc. $AMRX - marketbeat.com

JPMorgan Chase & Co. Has $7.72 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - marketbeat.com

Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by SG Americas Securities LLC - marketbeat.com

Amneal Pharmaceuticals (AMRX) price target increased by 13.79% to 16.83 - MSN

AMRX SEC FilingsAmneal Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Amneal (NYSE: AMRX) Co-CEO receives major performance-based RSU award - Stock Titan

[Form 4/A] Amneal Pharmaceuticals, Inc. Amended Insider Trading Activity - Stock Titan

Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openPR.com

Major holder Dipan Patel cuts Amneal Pharmaceuticals (AMRX) stake to 5.4% - Stock Titan

Vanguard (AMRX) disaggregates holdings, reports 0 Amneal shares after realignment - Stock Titan

Amneal Pharmaceuticals (NASDAQ: AMRX) posts 2025 growth and seeks backing for board slate - Stock Titan

Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Assenagon Asset Management S.A. - marketbeat.com

Amneal Pharmaceuticals stock gains momentum as Truist raises target to $17 amid analyst optimism - AD HOC NEWS

Oliver Luxxe Assets LLC Purchases New Position in Amneal Pharmaceuticals, Inc. $AMRX - marketbeat.com

Amneal Pharmaceuticals, Inc. (AMRX) added to S&P SmallCap 600 Index, boosting investor visibility - msn.com

Aug Selloffs: Whats the fair value of Amneal Pharmaceuticals Inc stock2026 Price Momentum & Technical Confirmation Trade Alerts - baoquankhu1.vn

How Amneal’s Margin-Focused 2026 Outlook and 2025 Results Could Impact Amneal Pharmaceuticals (AMRX) Investors - simplywall.st

A Look At Amneal Pharmaceuticals (AMRX) Valuation After Strong 2025 Results And 2026 Growth Guidance - simplywall.st

AMRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock? - MSN

Hydroxychloroquine Market Is Booming So Rapidly | Sanofi and Amneal Pharmaceuticals, LLC - openPR.com

Stock Recap: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Fundamental Recap & Long-Term Investment Growth Plans - baoquankhu1.vn

Aug Analyst Calls: What are the future prospects of Amneal Pharmaceuticals IncPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn

Retail Surge: Will Amneal Pharmaceuticals Inc benefit from green energy policies2026 Winners & Losers & Community Verified Swing Trade Signals - baoquankhu1.vn

Amneal Pharmaceuticals: Flattish 2026 Revenue Growth Aside, Stock Still Looks A Buy (AMRX) - Seeking Alpha

Algert Global LLC Cuts Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Amneal Recalls Three Lots Of UTI Drug Over Concerns of Microbial Contamination: Retail Sticks To Bearish Territory - MSN

Capula Management Ltd Buys New Shares in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

AMRX PE Ratio & Valuation, Is AMRX Overvalued - Intellectia AI

Is Amneal Pharmaceuticals (AMRX) Pricing Reflect Its DCF Gap And Recent Share Slide - Yahoo Finance

Fed Meeting: Does Amneal Pharmaceuticals Inc stock have upside surprise potential2026 Weekly Recap & Community Consensus Trade Alerts - baoquankhu1.vn

Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 5.5%Here's What Happened - MarketBeat

Amneal Pharmaceuticals Inc (AMRX) Shares Gap Down to $12.73 on M - GuruFocus

Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment - Yahoo Finance

What Amneal Pharmaceuticals (AMRX)'s Return to Profitability and 2026 Guidance Means For Shareholders - simplywall.st

Amneal Pharmaceuticals Conference: “Amneal 2.0” Targets 2026 Growth in Biosimilars, CREXONT and AvKARE Shift - MarketBeat

Amneal (AMRX) Stock Analysis 2026: Strong Gains vs. Future Growth ConcernsNews and Statistics - IndexBox

Shorts Report: Is Amneal Pharmaceuticals Inc a strong candidate for buy and holdForecast Cut & Weekly Stock Breakout Alerts - baoquankhu1.vn

3 Reasons to Avoid AMRX and 1 Stock to Buy Instead - Finviz

AMRX: Biosimilars and specialty launches fuel growth, with profitability and global expansion accelerating - TradingView

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Best Value Stocks to Buy for March 9th - The Globe and Mail

Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus - MSN

Trade Report: Will Amneal Pharmaceuticals Inc benefit from current market trends2026 Big Picture & Verified Trade Idea Suggestions - baoquankhu1.vn

Citigroup Inc. Purchases 101,166 Shares of Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat

Amneal Pharmaceuticals, Inc. $AMRX Shares Sold by Quantbot Technologies LP - MarketBeat

Goldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX) - The Globe and Mail

Amneal to Participate in Upcoming Investor Conference - National Today

Amneal (NYSE: AMRX) Co-CEO settles RSUs, withholds stock to cover taxes - Stock Titan

Amneal (AMRX) Co-CEO gains shares via RSU and performance awards - Stock Titan

Amneal (AMRX) EVP nets stock from RSU vesting and tax withholdings - Stock Titan

Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie AMRX